TIMP3 and chondrosarcoma: The ability of the analogs to promote TIMP-3 accumulation was assessed by incubating HTB94 chondrosarcoma cells with suramin or the suramin analogs (200 μg/ml) for 36 hours and quantifying TIMP-3 levels in the medium by immunoblotting.